Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/18/2024 09:26 PM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20170&cosponId=24466
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2017 - 2018 Regular Session

MEMORANDUM

Posted: August 31, 2017 02:55 PM
From: Representative Lynda Schlegel Culver
To: All House members
Subject: Proposed Resolution
 
I am planning to introduce a Resolution designating the month of September, 2017 as "Histiocytosis Awareness Month" in Pennsylvania.

Histiocytosis is a general name for a group of rare disorders that involve an abnormal increase in the number of specialized white blood cells that are called histiocytes.

In 1987, the Histiocyte Society first classified this group of disorders into three categories.

The first category, dendritic cell disorder, includes Langerhans cell histosis, juvenile xanthogranuloma and Erdheim-Chester disease.

The second category, macrophage cell disorder, includes hemophagoctyic lymphohistiocytosis and Rosai-Dorfman disease.

The third category, malignant histiocytosis includes certain kinds of leukemia and malignant tumors.

There are multiple competing classification systems, including a proposed five category system.

Chemotherapy is a common treatment for histiocytosic disorders.

Histiocytosic disorders can affect children or adults and more research is needed to help those impacted by the disorders.

Please join me in cosponsoring this resolution.



Introduced as HR509